134 related articles for article (PubMed ID: 37311657)
1. Ηeparan sulphate in infectious and non-infectious exacerbations of COPD.
Papakonstantinou E; Christopoulou ME; Karakioulaki M; Grize L; Tamm M; Stolz D
Respirology; 2023 Aug; 28(8):767-774. PubMed ID: 37311657
[TBL] [Abstract][Full Text] [Related]
2. Variability of fractional exhaled nitric oxide is associated with the risk and aetiology of COPD exacerbations.
Schumann DM; Papakonstantinou E; Kostikas K; Grize L; Tamm M; Stolz D
Respirology; 2023 May; 28(5):445-454. PubMed ID: 36571108
[TBL] [Abstract][Full Text] [Related]
3. Time-course of upper respiratory tract viral infection and COPD exacerbation.
Stolz D; Papakonstantinou E; Grize L; Schilter D; Strobel W; Louis R; Schindler C; Hirsch HH; Tamm M
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31391222
[TBL] [Abstract][Full Text] [Related]
4. Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T.
Søyseth V; Bhatnagar R; Holmedahl NH; Neukamm A; Høiseth AD; Hagve TA; Einvik G; Omland T
Heart; 2013 Jan; 99(2):122-6. PubMed ID: 23024006
[TBL] [Abstract][Full Text] [Related]
5. A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD.
Wilkinson TMA; Aris E; Bourne S; Clarke SC; Peeters M; Pascal TG; Schoonbroodt S; Tuck AC; Kim V; Ostridge K; Staples KJ; Williams N; Williams A; Wootton S; Devaster JM;
Thorax; 2017 Oct; 72(10):919-927. PubMed ID: 28432209
[TBL] [Abstract][Full Text] [Related]
6. Study of respiratory viruses and their coinfection with bacterial and fungal pathogens in acute exacerbation of chronic obstructive pulmonary diseases.
Jahan R; Mishra B; Behera B; Mohapatra PR; Praharaj AK
Lung India; 2021; 38(1):53-58. PubMed ID: 33402638
[TBL] [Abstract][Full Text] [Related]
7. Analysis of viral infection and biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease.
Yin T; Zhu Z; Mei Z; Feng J; Zhang W; He Y; Shi J; Qian L; Liu Y; Huang Q; Hu Y; Jie Z
Clin Respir J; 2018 Mar; 12(3):1228-1239. PubMed ID: 28586150
[TBL] [Abstract][Full Text] [Related]
8. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].
Jiang M; Ma JF
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002
[TBL] [Abstract][Full Text] [Related]
9. Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation.
Yerkovich ST; Hales BJ; Carroll ML; Burel JG; Towers MA; Smith DJ; Thomas WR; Upham JW
BMC Pulm Med; 2012 Jul; 12():37. PubMed ID: 22849333
[TBL] [Abstract][Full Text] [Related]
10. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
[TBL] [Abstract][Full Text] [Related]
11. Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study.
Bourne S; Cohet C; Kim V; Barton A; Tuck A; Aris E; Mesia-Vela S; Devaster JM; Ballou WR; Clarke SC; Wilkinson T
BMJ Open; 2014 Mar; 4(3):e004546. PubMed ID: 24607562
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease.
Nishimura K; Nishimura T; Onishi K; Oga T; Hasegawa Y; Jones PW
Int J Chron Obstruct Pulmon Dis; 2014; 9():155-62. PubMed ID: 24523584
[TBL] [Abstract][Full Text] [Related]
13. Resolving Viral-Induced Secondary Bacterial Infection in COPD: A Concise Review.
Wang H; Anthony D; Selemidis S; Vlahos R; Bozinovski S
Front Immunol; 2018; 9():2345. PubMed ID: 30459754
[TBL] [Abstract][Full Text] [Related]
14. Differences in plasma amino acid levels in patients with and without bacterial infection during the early stage of acute exacerbation of COPD.
Inoue S; Ikeda H
Int J Chron Obstruct Pulmon Dis; 2019; 14():575-583. PubMed ID: 30880947
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of circulating exosome in COPD patients are associated with systemic inflammation.
Tan DBA; Armitage J; Teo TH; Ong NE; Shin H; Moodley YP
Respir Med; 2017 Nov; 132():261-264. PubMed ID: 28476471
[TBL] [Abstract][Full Text] [Related]
16. Expiratory central airway collapse in stable COPD and during exacerbations.
Leong P; Tran A; Rangaswamy J; Ruane LE; Fernando MW; MacDonald MI; Lau KK; Bardin PG
Respir Res; 2017 Aug; 18(1):163. PubMed ID: 28841915
[TBL] [Abstract][Full Text] [Related]
17. Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study.
Husebø GR; Bakke PS; Aanerud M; Hardie JA; Ueland T; Grønseth R; Persson LJ; Aukrust P; Eagan TM
PLoS One; 2014; 9(10):e109721. PubMed ID: 25279458
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of lncRNA MALAT1 and its targets miR-125b, miR-133, miR-146a, and miR-203 for predicting disease progression in chronic obstructive pulmonary disease patients.
Liu S; Liu M; Dong L
J Clin Lab Anal; 2020 Sep; 34(9):e23410. PubMed ID: 32583510
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.
Persson LJ; Aanerud M; Hardie JA; Miodini Nilsen R; Bakke PS; Eagan TM; Hiemstra PS
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28298400
[TBL] [Abstract][Full Text] [Related]
20. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
